BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18717603)

  • 1. EGFR inhibitor-associated acneiform folliculitis: assessment and management.
    Duvic M
    Am J Clin Dermatol; 2008; 9(5):285-94. PubMed ID: 18717603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis.
    Tomková H; Pospíšková M; Zábojníková M; Kohoutek M; Serclová M; Gharibyar M; Sternberský J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):514-9. PubMed ID: 22035385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous side effects of EGF receptor inhibitors].
    Nassar D; Soutou B; Aractingi S
    Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
    Cholongitas E; Pipili C; Ioannidou D
    J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab-induced acne.
    Molinari E; De Quatrebarbes J; André T; Aractingi S
    Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Requena C; Llombart B; Sanmartín O
    Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
    Lenz HJ
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):5-13. PubMed ID: 16736978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne.
    Yu HJ; Lee SK; Son SJ; Kim YS; Yang HY; Kim JH
    Int J Dermatol; 1998 Oct; 37(10):772-7. PubMed ID: 9802688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Shin JU; Park JH; Cho BC; Lee JH
    Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
    Gencoglan G; Ceylan C
    Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for acne.
    James KA; Burkhart CN; Morrell DS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):649-59. PubMed ID: 19772370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tufted hair folliculitis in a woman treated with trastuzumab.
    Rosman IS; Anadkat MJ
    Target Oncol; 2010 Dec; 5(4):295-6. PubMed ID: 20949375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections.
    Braden RL; Anadkat MJ
    Support Care Cancer; 2016 Sep; 24(9):3943-50. PubMed ID: 27117557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of the amounts and expressions of epidermal growth factor, epidermal growth factor receptor, and epidermal growth factor receptor gene polymorphisms in acne vulgaris.
    Aydingoz IE; Tukenmez Demirci G; Agirbasli D; Oz-Arslan D; Yenmis G
    J Cosmet Dermatol; 2021 Jan; 20(1):346-351. PubMed ID: 32421896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin signs associated with epidermal growth factor inhibitors].
    Hannoud S; Rixe O; Bloch J; Le Pelletier F; Lebrun-Vignes B; Doarika A; Khayat D; Chosidow O
    Ann Dermatol Venereol; 2006 Mar; 133(3):239-42. PubMed ID: 16800173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxysmal iatrogenic acne and the epidermal growth factor receptor inhibitors (EGFR)].
    Piérard-Franchimont C; Blaise G; Paquet P; Quatresooz R; Rorive A; Piérard GE
    Rev Med Liege; 2007 Jan; 62(1):11-4. PubMed ID: 17343123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous lesions due to inhibition of epidermal growth factor receptor].
    Bierhoff E; Seifert HW; Dirschka T
    Pathologe; 2006 Feb; 27(1):53-6. PubMed ID: 16362261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gefitinib-associated folliculitis.
    Matheis P; Socinski MA; Burkhart C; Warren S; Thomas NE
    J Am Acad Dermatol; 2006 Oct; 55(4):710-3. PubMed ID: 17010757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J; Cencelj S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.